SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-051686
Filing Date
2020-04-27
Accepted
2020-04-27 17:05:35
Documents
4
Period of Report
2020-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2016771d1_8k.htm 8-K 23240
2 EXHIBIT 10.1 tm2016771d1_ex10-1.htm EX-10.1 116866
3 EXHIBIT 99.1 tm2016771d1_ex99-1.htm EX-99.1 17440
4 GRAPHIC image_002.jpg GRAPHIC 15435
  Complete submission text file 0001104659-20-051686.txt   180419
Mailing Address 7 DEER PARK DRIVE, SUITE K MONMOUTH JUNCTION NJ 08852
Business Address 7 DEER PARK DRIVE, SUITE K MONMOUTH JUNCTION NJ 08852 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

IRS No.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 20820994
SIC: 3841 Surgical & Medical Instruments & Apparatus